Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0Z3JI
|
||||
Former ID |
DNC002579
|
||||
Drug Name |
N1,N14-Bis((S-Methyl)Isothioureido)Tetradecane
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [551393] | ||
Structure |
Download2D MOL |
||||
Formula |
C6H14N2S
|
||||
Canonical SMILES |
CCCCN=C(N)SC
|
||||
InChI |
1S/C6H14N2S/c1-3-4-5-8-6(7)9-2/h3-5H2,1-2H3,(H2,7,8)
|
||||
InChIKey |
WLIDQCHXBFDAKG-UHFFFAOYSA-N
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Nitric-oxide synthase, endothelial | Target Info | Inhibitor | [551393] | |
BioCyc Pathway | Citrulline-nitric oxide cycle | ||||
NetPath Pathway | Wnt Signaling Pathway | ||||
Pathway Interaction Database | Plasma membrane estrogen receptor signaling | ||||
Validated transcriptional targets of AP1 family members Fra1 and Fra2 | |||||
Angiopoietin receptor Tie2-mediated signaling | |||||
Thromboxane A2 receptor signaling | |||||
SHP2 signaling | |||||
VEGFR1 specific signals | |||||
Signaling events mediated by VEGFR1 and VEGFR2 | |||||
PAR1-mediated thrombin signaling events | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.